fluoxetine

8 interactions related to fluoxetine

fluoxetine + sam-e

SAM-e has independent antidepressant and serotonergic activity, and combining it with fluoxetine can additively raise serotonergic tone, increasing the risk of serotonin syndrome and hypomania. Fluoxetine's long half-life means this risk persists for weeks after the last dose.

high
fluoxetinesam-eprozacssriserotonin syndromedepressionaugmentationinteraction

fluoxetine + kava

Kava carries a documented risk of hepatotoxicity and produces CNS depression, and combining it with fluoxetine raises the risk of additive sedation and liver injury. Kava also inhibits CYP2D6 and CYP3A4, the enzymes that metabolize fluoxetine, which can elevate fluoxetine levels and side effects.

high
fluoxetinekavaprozacssrihepatotoxicityanxietysedationcyp2d6

fluoxetine + tryptophan

Fluoxetine blocks serotonin reuptake while tryptophan supplies raw material for serotonin synthesis, and the combination can produce serotonin syndrome. Fluoxetine's very long half-life (active metabolite norfluoxetine persists for weeks) extends the window of risk well beyond the last dose.

high
fluoxetinetryptophanprozacssriserotonin syndrome5-htpantidepressantinteraction

fluoxetine + saffron

Saffron (Crocus sativus) has independent antidepressant activity, including serotonergic effects demonstrated in randomized controlled trials, and combining it with fluoxetine can theoretically add to serotonergic tone. Fluoxetine's long half-life extends the window of potential interaction for weeks after the last dose.

moderate
fluoxetinesaffronprozacssriserotonincrocus sativusdepressioninteraction

fluoxetine + st. john's wort

Fluoxetine is an SSRI with a very long half-life (its active metabolite norfluoxetine persists for weeks), and St. John's wort independently raises serotonin via reuptake inhibition. Combined use can precipitate serotonin syndrome and, because of fluoxetine's slow elimination, the risk window extends well beyond the day of last dose.

critical
fluoxetineprozacssrist johns wortserotonin syndromehypericumantidepressantlong half-lifecontraindication

cannabis + ssris

Cannabis cannabinoids inhibit CYP2C19, CYP2C9, and CYP3A4, raising plasma levels of SSRIs such as sertraline, citalopram, and escitalopram. Cannabinoids also modulate serotonin signaling, and case reports describe serotonin syndrome precipitated by high-potency cannabis in patients on SSRIs.

high
cannabismarijuanassriserotonin syndromesertralinefluoxetinecitalopramantidepressantscyp2c19

fluoxetine + 5-htp

Fluoxetine is an SSRI that blocks serotonin reuptake, and 5-HTP is the direct precursor that the body converts into serotonin. Combining them can raise synaptic serotonin to levels associated with serotonin syndrome, and fluoxetine's long-lived active metabolite norfluoxetine extends this risk for weeks after the last dose.

high
fluoxetineprozac5-htp5-hydroxytryptophanssriserotonin syndrometryptophansupplementwarning

alcohol + fluoxetine

Fluoxetine (Prozac) and alcohol both depress the central nervous system, increasing drowsiness, dizziness, and impaired judgment. Fluoxetine and its active metabolite norfluoxetine have unusually long half-lives (1 to 4 days and 4 to 16 days), so alcohol effects can be amplified even when the drink and dose are taken hours apart.

moderate
alcoholfluoxetineprozacssriantidepressantlong half lifecns depressantdepressiondrug interaction